Regulatory Press Releases

The meeting resolved, in accordance with the shareholder Linc AB’s proposal, that the board of directors shall consist of six board members with no deputies. Furthermore, the meeting resolved to elect Victor Steien as new ordinary member of the board of directors and that Victor Steien shall receive SEK 135,000 in annual remuneration, adjusted for the service time as a member of the board of...

NOTICE OF EXTRAORDINARY GENERAL MEETING OF STILLE AB Stille AB holds an extraordinary general meeting on Friday, December 29, 2023 at 09:00 am at the company’s offices at Ekbacken 11, 644 30 Torshälla, Sweden. Registration starts at 08:30 am. Shareholders wishing to attend the meeting must: (i) be recorded as a shareholder in the share register kept by Euroclear Sweden AB on the record...

The board of directors of Stille has resolved on the Directed Share Issue of 3,971,963 new shares at a subscription price of SEK 107 per share, subject to approval at an extraordinary general meeting to be held on 29 December 2023. Through the Directed Share Issue the Company will receive gross proceeds of approximately SEK 425 million before transaction related costs. “We are very pleased with...

Fehling is a family-owned German company, founded in 1996, that develops and sells high-quality medical instruments. Fehling has a strong market position with direct operations in Germany, Switzerland, USA, Singapore, UAE, and Malaysia. With over 30 years of industry experience, Fehling strives to provide a broad range of premium products to surgeons, with focus on demanding specialties such as open...

Revenue increased in the third quarter by 17.7 percent to 70.1 MSEK (59.6) after strong growth from both business units. “I am pleased to see that our strong growth compared to previous year continued in the third quarter”, comments Torbjörn Sköld. The gross profit amounted to 46.7 percent (45.1). Business unit Surgical Tables was affected by an unfavorable product and market...